The Effects of Growth Hormone Treatment on Health-Related Quality of Life in Children
Authors:
- L. SheppardLSL. Sheppard
- C. EiserCEC. Eiser
- H.A. DaviesHDH.A. Davies
- S. CarneySCS. Carney
- S.A. ClarkeSCS.A. Clarke
- T. UrquhartTUT. Urquhart
- M.J. RyderMRM.J. Ryder
- A. StonerASA. Stoner
- N.P. WrightNWN.P. Wright
- G. ButlerGBG. Butler
- 1 April 2006
- journal article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 65 (5) , 243-249
Abstract
Background/Aims: The effects of growth hormone deficiency (GHD) on linear growth in children are well documented, but there is less convincing evidence regarding the impact on health-related quality of life (QOL). We examined QOL in children aged 8–16 years with acquired GHD following treatment for malignancy (AGHD) or idiopathic GHD (IGHD) on commencing growth hormone treatment (GHT) over 6 months. We adopted a longitudinal design involving consecutive patients and their families attending clinic over an 18-month period. Mothers and children were invited to complete questionnaires before GHT (T1) and 6 months later (T2). Methods: Mothers of 22 children (AGHD n = 14; IGHD n = 8) completed standardized measures of child QOL and behaviour. Children completed parallel measures of QOL, short-term memory tasks and fitness either in clinic or at the family home. Results: For children with AGHD, QOL was significantly below population norms at T1 and improved over time. For children diagnosed with IGHD, QOL at T1 was below, but comparable with population norms. QOL improved over time, though not significantly. Conclusion: GHT is potentially valuable for improving QOL in children, especially in cases of AGHD. We conclude that benefits of GHT for QOL need to be evaluated independent of different diagnostic groups.Keywords
This publication has 32 references indexed in Scilit:
- Growth Hormone Treatment and Quality of Life among Survivors of Childhood CancerHormone Research in Paediatrics, 2005
- Hypothalamo‐pituitary‐adrenal axis integrity after cranial irradiation for childhood posterior fossa tumoursMedical and Pediatric Oncology, 2003
- Cranial radiotherapy of childhood brain tumours: Growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based studyClinical Endocrinology, 2000
- Survivors of childhood cancer: long‐term edocrine and metabolic problems dwarf the growth distrubanceActa Paediatrica, 1999
- Psychological response to growth hormone treatment in short normal children.Archives of Disease in Childhood, 1996
- Growth, puberty and obesity after treatment for leukaemiaActa Paediatrica, 1995
- Factors influencing the desire for long‐term growth hormone replacement in adultsClinical Endocrinology, 1995
- Growth and puberty after growth hormone treatment after irradiation for brain tumours.Archives of Disease in Childhood, 1995
- Recruiting patients to clinical trials: lessons from studies of growth hormone treatment in renal failure.Archives of Disease in Childhood, 1995
- Body mass index reference curves for the UK, 1990.Archives of Disease in Childhood, 1995